acetylcysteine has been researched along with beraprost in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Itoh, Y; Oishi, R; Sendo, T; Yano, T | 1 |
| Baba, A; Itoh, Y; Matsuo, M; Mishima, K; Oishi, R | 1 |
| Yano, T | 1 |
2 review(s) available for acetylcysteine and beraprost
| Article | Year |
|---|---|
Clinical and experimental evidence for prevention of acute renal failure induced by radiographic contrast media.
Topics: Acetylcysteine; Acute Kidney Injury; Adenosine; Alprostadil; Animals; Apoptosis; Ascorbic Acid; Atrial Natriuretic Factor; Contrast Media; Diuretics; Endothelins; Epoprostenol; Fenoldopam; Fluid Therapy; Hemodiafiltration; Hemofiltration; Humans; Iodine Radioisotopes; Kidney Tubules; Models, Biological; Renal Dialysis; Risk Factors | 2005 |
[Etiology of iodinated radiocontrast nephrotoxicity and its attenuation by beraprost].
Topics: Acetylcysteine; Animals; Apoptosis; Ceramides; Contrast Media; Cyclic AMP Response Element-Binding Protein; Enzyme Inhibitors; Epoprostenol; Fumonisins; Humans; Iodine Compounds; Kidney Diseases; Kidney Tubules; Mice; Phosphorylation; Proto-Oncogene Proteins c-bcl-2 | 2008 |
2 other study(ies) available for acetylcysteine and beraprost
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Protective effect of cyclic AMP against cisplatin-induced nephrotoxicity.
Topics: Acetylcysteine; Animals; Antineoplastic Agents; Antioxidants; Apoptosis; Chemical and Drug Induced Liver Injury; Cisplatin; Cyclic AMP; Enzyme Activation; Enzyme Inhibitors; Epoprostenol; Fluorescent Antibody Technique; In Situ Nick-End Labeling; Lipid Peroxidation; Liver Diseases; Male; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Wistar; Reactive Oxygen Species; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2006 |